DAFNA Buys $2M of 10% Convertible Notes, Discloses 15.3% Stereotaxis Stake
STXS is trading near its 52-week low of $0.8 (8.2% above the low) on elevated volume (2.3× avg).
Summary
DAFNA Capital and affiliated funds bought $2.0M of Stereotaxis's 10% convertible notes at a $1.21 conversion price, lifting the group's beneficial ownership to 15.3% including 1.65M conversion shares.
Key Events · Ownership and Investor Activity · STXS
-
Insider Fund Buys $2M of Convertible Notes
Through LifeScience and Select, DAFNA purchased $2,000,000 principal of Stereotaxis's 10% convertible notes, convertible at $1.21 per share into 1,652,892 shares.
-
Group Stake Reaches 15.3%
Dr. Nathan Fischel reports 15,628,395 shares (15.3%), including 294,949 restricted shares; DAFNA and Dr. Ghodsian report 15,333,446 shares (15.1%), based on 100,202,178 shares outstanding as of July 31, 2026 plus conversion shares.
-
Conversion Price Well Above Market
At $1.21, the conversion price is roughly 40% above today's $0.8653 quote, leaving the notes' equity option currently out of the money; a 19.9% beneficial ownership limitation caps conversion.
-
Follows November 10 Financing Announcement
This filing adds insider allocation detail to the $12M 10% convertible note raise disclosed in the 2026-11-10 8-K, which noted another $12M available.
Analysis · STXS · Industrial Applications And Services
A long-standing institutional holder — DAFNA has been filing amendments since 2016 — put real money into the same 10% convertible notes Stereotaxis announced on November 10, taking $2.0M of principal convertible at $1.21. That conversion price sits roughly 40% above today's $0.8653 quote, so the conversion feature is currently out of the money. The group now reports 15.3% beneficial ownership including 1,652,892 conversion shares, a large, concentrated position in a sub-$100M company. A 19.9% ownership blocker on the notes caps how much can be converted, limiting near-term share issuance from this holder. The takeaway: an existing large holder is funding the balance sheet on terms that price the equity well above the current market — supportive of the capital raise, though the conversion overhang and the 15%+ stake give DAFNA meaningful influence.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STXS was trading at $0.87 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $85.2M. The 52-week trading range was $0.80 to $2.86. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.